Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
June 20, 2022
Polish patients and physicians will soon be able to benefit from Hemolens Diagnostics groundbreaking non-invasive solutions for the diagnosis of coronary heart disease.
What are the advantages of our technology?
Cardiolens FFR-CT Pro® diagnostics is a completely non-invasive anatomical and functional diagnosis of the coronary arteries, which can be performed on an outpatient basis (no hospitalization required). It carries no risk of side effects or complications e.g. associated with invasive diagnostics.
The use of computational fluid dynamics, provides full diagnostic precision, while maintaining personalized patient outcomes. Our technology, supports physicians in making optimal therapeutic decisions for the patient and reduces the risk of error.
Hemolens Diagnostics solutions have virtually no limits to further technological development. We believe that our diagnostic methods dedicated to vascular diseases have the potential to become the “gold standard” worldwide, not only in cardiology but also in other fields such as oncology, pulmonology, angiology and neurology.